COVID-19MEDICAL personnelANTIBIOTICSHOSPITAL admission & dischargeCOVID-19 treatmentAntimicrobial resistance (AMR) is a global concern, and antibiotic use has risen throughout the COVID-19 pandemic. Up to 75% of COVID-19 patients are treated with antibiotics despite littl...
After controlling for COVID-19 risk factors including age, sex, and underlyingmedical conditions, the analyses found that clinical improvement in patients with moderate disease was significantly better for younger, female, and vaccinated patients. Importantly, patients given antibiotics had five times gre...
pneumoniae (26.3, 7.4%) were not influenced by overuse of meropenem, neither during COVID-19 or the following years. K. pneumoniae antimicrobial resistance rates and antibiotic usage CONCLUSION. Besides overuse of Beta-lactam antibiotics such as ceftriaxone and meropenem during the COVID-19 pandemic...
COVID-19respiratory virusesantibiotic stewardshipBACKGROUND. Significant concerns have been raised regarding the overuse of antibiotics among patients hospitalized for COVID-19 and the broad impact of the pandemic on antimicrobial stewardship in acute care. We sought to compare potentially unnecessary ...
Azithromycin has been used successfully as an antibiotic for many years and recently showed promising effects in a combination treatment with chloroquine to fight COVID-19.关键词: azithromycin Beckmann rearrangement antibiotic SARS-CoV-2 DOI: 10.1055/S-0040-1706961 ...
In an illness where the infection is due to a virus, such as a cough, cold, the flu or COVID, patients should not ask or demand that their health care provider prescribe an antibiotic. The antibiotic will not cure the viral infection, and the patient may have side effects from ...
Bacterial co-infection and secondary infection rarely affected patients with COVID-19 in Japan, and the isolated pathogens were not specific to these patients. Moreover, the anti-inflammatory effects of macrolides for COVID-19 were not observed in several studies. These results might be useful in...
In regions with high rates of COVID-19 spread, such as Europe and the United States, prescriptions for antibiotics in the community dropped dramatically after COVID-19 restrictions were introduced in early 2020. A study published in the British Journal o
Early in the COVID-19 pandemic, several unproven therapies were used, including antibiotics. In November 2020 and December 2021, monoclonal antibodies and oral antivirals were authorized for the outpatient treatment for COVID-19 respectively, which may have influenced inappropriate antibiotic prescribing...
The lowest rates were seen in patients ≥66 years (48.5%), whereas the highest rate of prior antibiotic use was observed for the 31–45-year group (75.2%). Figure 1. Pre-admission antibiotic use stratified across age groups. The most frequently used antibiotics used for COVID-19 ...